Diagnostic Accuracy of Different Bronchoscopic Sampling Techniques in Patients With Mediastinal Lymph Node Enlargement Suspected of Sarcoidosis
- provided informed consent
- mediastinal lymph node enlargement that requires bronchoscopy and transbronchial
- clinical presentation that might be consistent with sarcoidosis
- age below 18 years
- known contraindications for bronchoscopy and/or mediastinal sampling, e.g.
- lung or extrapulmonary tumors with suspicion of malignant mediastinal lymph node
Type of Study:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic
Accuracy of different bronchoscopic sampling methods in making the diagnosis of sarcoidosis.
Comparison of the diagnostic yield of the cytologic and histologic specimens collected by EBUS-TBNA , EBUS-TBFB and large bore TBNA in terms of making the diagnosis of sarcoidosis.
Outcome Time Frame:
Approximately ten days after the procedure, when the results of the cytological and histopathological examination will be available
Poland: Bioethics Appeals Commission
- Mediastinal Lymph Node Enlargement
- mediastinal lymph node enlargement
- EBUS guided transbronchial needle aspiration (EBUS-TBNA)
- transbronchial needle aspiration (EBUS-TBNA)
- EBUS guided transbronchial forceps biopsy EBUS-TBFB)
- Lymphatic Diseases